Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 5—May 2026

Research

Updated Genomic Epidemiologic Description of Candida (Candidozyma) auris, United States

Lindsay A. ParnellComments to Author , Amanda Ribeiro Dos Santos, Kaitlin Forsberg, Meghan Lyman, Elizabeth Misas, Lalitha Gade, D. Joseph Sexton, Anastasia P. Litvintseva, and Nancy A. Chow
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table

Patient demographic data and clinical information for isolates sequenced in study of genomic epidemiologic description of Candida (Candidozyma) auris, United States

Characteristic No. (%) cases
All, n = 1,535 Central, n = 9 Mid-Atlantic, n = 188 Midwest, n = 234 Mountain, n = 87 Northeast, n = 560 Southeast, n = 181 West, n = 276
Case type
Clinical 736 (48) 8 (89) 55 (29) 101 (43) 29 (33) 250 (45) 156 (86) 137 (50)
Screening* 728 (47) 1 (11) 120 (64) 132 (56) 58 (67) 266 (48) 16 (9) 135 (49)
Unknown
71 (5)
0
13 (7)
1 (0.43)
0
44 (8)
9 (5)
4 (1)
Specimen type
Colonization screening sites 727 (47) 1 (11) 120 (64) 132 (56) 58 (67) 265 (47) 16 (9) 135 (49)
Blood 293 (19) 3 (33) 18 (10) 34 (15) 13 (15) 94 (17) 70 (39) 61 (22)
Ear 9 (1) 1 (11) 0 1 (0.43) 0 5 (1)* 1 (1) 1
Fluid and drainage 20 (1) 0 3 (2) 3 (1) 0 9 (2) 1 (1) 4 (1)
Indwelling device 10 (1) 0 0 4 (2) 0 3 (1) 0 3 (1)
Respiratory 80 (5) 0 4 (2) 8 (3) 5 (6) 28 (5) 24 (13) 11 (4)
Urine 210 (14) 2 (22) 21 (11) 35 (15) 8 (9) 75 (13) 34 (19) 35 (13)
Wound 55 (4) 0 8 (4) 7 (3) 2 (2) 16 (3) 17 (9) 5 (2)
Other 89 (6) 2 (22) 1 (1) 9 (4) 1 (1) 48 (9) 9 (5) 19 (7)
Unknown
42 (3)
0
13 (7)
1 (0.43)
0
17 (3)
9 (5)
2 (1)
Age, y
<21 10 (1) 0 1 (1) 1 (0.43) 0 2 2 (1) 4 (1)
>21 to <64 629 (41) 5 (56) 97 (52) 127 (54) 46 (53) 183 (33) 70 (39) 101 (37)
>65 793 (52) 2 (22) 78 (41) 83 (35) 41 (47) 316 (56) 104 (57) 169 (61)
Unknown
103 (7)
2 (22)
12 (6)
23 (10)
0
59 (11)
5 (3)
2 (1)
Sex
F 519 (34) 0 72 (38) 72 (31) 31 (36) 199 (36) 54 (30) 91 (33)
M 687 (45) 7 (78) 87 (46) 100 (43) 42 (48) 255 (46) 63 (35) 133 (48)
Unknown
329 (21)
2 (22)
29 (15)
62 (26)
14 (16)
106 (19)
64 (35)
52 (19)
Year of collection
2013 1 (0.07) 0 0 0 0 1 (0.18) 0 0
2014 0 0 0 0 0 0 0 0
2015 1 (0.07) 0 0 0 0 1 (0.18) 0 0
2016 100 (7) 0 6 (3) 22 (9) 0 72 (13) 0 0
2017 350 (23) 2 (22) 3 (2) 22 (9) 0 317 (57) 5 (3) 1 (0.36)
2018 123 (8) 1 (11) 3 (2) 54 (23) 1 (1) 59 (11) 4 (2) 1 (0.36)
2019 134 (9) 1 (11) 21 (11) 5 (2) 8 (9) 7 (1) 39 (22) 53 (19)
2020 295 (19) 2 (22) 61 (32) 32 (14) 2 (2) 17 (3) 84 (46) 97 (35)
2021 386 (25) 2 (22) 93 (49) 82 (35) 62 (71) 37 (7) 43 (24) 67 (24)
2022 145 (9) 1 (11) 1 (1) 17 (7) 14 (16) 49 (9) 6 (3) 57 (21)

*One early ear case in the Northeast was counted as a screening case because of circumstances of collection and case definition at the time.

Main Article

Page created: April 01, 2026
Page updated: April 23, 2026
Page reviewed: April 23, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external